Single Peptides · Exact presentation
Ara-290 · 16 mg Vial
Ara-290 · 16 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 16 mg presentation, the reference concentration of 8 mg/mL mathematically corresponds to 2 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 8 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.08 mg at this concentration.
Standard / Gradual Approach (2.0 mL = 8 mg/mL)
The source chart summarizes “2 mg–4 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (2.0 mL = 8 mg/mL)
| Week | Daily Dose | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 2 mg (2,000 mcg) | 25 units (0.25 mL) |
| Weeks 2–8 (or up to 16) | 4 mg (4,000 mcg) | 50 units (0.50 mL) |
Reconstitution Steps
For a 16 mg presentation, the reference concentration of 8 mg/mL mathematically corresponds to 2 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 8 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.08 mg at this concentration.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
It is studied in signaling pathways related to extracellular matrix, cell migration, inflammation, or tissue repair. Relevance depends on the compound and experimental model.
Potential Benefits & Side Effects
Preclinical results do not necessarily predict human safety or efficacy. Identity, route, formulation, and study quality must be reviewed.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Ara-290 · 16 mg Vial entrysecondary-structure
- PubMed — literature search for Ara-290primary-discovery
- ClinicalTrials.gov — study search for Ara-290trial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference